News Releases

04/24/2025
EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia
SINGAPORE , April 24, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited  (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore -based property management services provider and a leading non-invasive healthcare provider in Singapore and Malaysia , today announced an update to the potential 
12/16/2024
EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation
–         Preliminary   Discussions   Underway   to   Establish   a   Joint   Venture SINGAPORE , Dec. 16, 2024 (GLOBE NEWSWIRE) — EUDA   Health   Holdings   Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore -based health technology company that operates a first-of-its-kind Southeast 
05/08/2024
EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia
Singapore, May 08, 2024 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, proudly announces the successful completion of its 
05/06/2024
EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health
SINGAPORE, May 06, 2024 (GLOBE NEWSWIRE) —  EUDA Health Holdings Limited  (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it will acquire CK Health Plus Sdn 
01/16/2024
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) — As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Nasdaq on January 9, 2024 indicating that the Company had failed to maintain a minimum market value of listed securities of $35 million over 
01/16/2024
EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on January 9, 2024 indicating that the Company had failed to maintain a 
10/05/2023
EUDA Health Holdings Limited Enters into Letter of Intent for Proposed Merger with TheoremRx Inc.
SINGAPORE, Oct. 05, 2023 (GLOBE NEWSWIRE) —  EUDA Health Holdings Limited  (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering enhanced outcomes through 
09/22/2023
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements
Singapore, Sept. 22, 2023 (GLOBE NEWSWIRE) — As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on August 10, 2023 indicating that the Company was not in compliance 
08/14/2023
EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Requirement
Singapore, Aug. 14, 2023 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 Minimum Bid 
08/04/2023
EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
Singapore, Aug. 04, 2023 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (“EUDA” and the “Company”) received a notice (the “MVLS Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company’s listed securities failed to comply with the $35 million market value of listed 
11/23/2022
8i Acquisition 2 Corp. and EUDA Health Ltd Complete Business Combination
Singapore, Nov. 23, 2022 (GLOBE NEWSWIRE) —  8i Acquisition 2 Corp.  (the “Company” or “LAX”) (NASDAQ: LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the “Business Combination”) with  EUDA Health Ltd  (“EUDA Health”), a 

►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Scroll to Top